Globus Medical Inc
NYSE:GMED
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
44.46
84.91
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one GMED stock under the Base Case scenario is 85.38 USD. Compared to the current market price of 84.72 USD, Globus Medical Inc is Undervalued by 1%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Globus Medical Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for GMED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Globus Medical Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Globus Medical Inc. is a prominent player in the expanding spinal surgery market, leveraging innovation and patient-centric solutions to elevate the standards of care in orthopedic surgery. Founded in 2003, the company has quickly established itself as a leader by developing a comprehensive range of spinal implants and surgical instruments that emphasize minimally invasive techniques. This focus not only enhances patient recovery but also supports surgeons in their pursuit of optimal outcomes. With a robust pipeline of products and a commitment to research and development, Globus Medical aims to maintain its competitive edge by addressing the evolving needs of healthcare professionals and pa...
Globus Medical Inc. is a prominent player in the expanding spinal surgery market, leveraging innovation and patient-centric solutions to elevate the standards of care in orthopedic surgery. Founded in 2003, the company has quickly established itself as a leader by developing a comprehensive range of spinal implants and surgical instruments that emphasize minimally invasive techniques. This focus not only enhances patient recovery but also supports surgeons in their pursuit of optimal outcomes. With a robust pipeline of products and a commitment to research and development, Globus Medical aims to maintain its competitive edge by addressing the evolving needs of healthcare professionals and patients alike.
For investors, Globus Medical represents a compelling opportunity, as its strong revenue growth and strategic initiatives indicate a promising future. The company has experienced consistent financial performance, underpinned by a growing market demand for spine-related procedures due to aging demographics and an increase in sports-related injuries. Moreover, Globus has pursued strategic acquisitions and collaborations, which have expanded its product offerings and geographical reach. As healthcare systems increasingly prioritize efficiency and patient outcomes, Globus Medical's innovative approach equips it to thrive in an industry ripe with potential, making it an attractive investment choice for those looking to capitalize on the evolving landscape of medical technology.
Globus Medical Inc. is a company focused on the development of innovative spinal surgery products and solutions. The core business segments of Globus Medical primarily include:
-
Spinal Implants: This segment includes a range of products designed for various spinal pathologies, including degenerative conditions, trauma, and deformity. The implants are made from materials such as titanium and PEEK, and the product offerings include interbody devices, cervical plates, and fixation systems.
-
Surgical Instruments: Globus Medical offers a variety of surgical tools and instruments that complement its spinal implant products. These instruments are designed to assist surgeons in performing safe and effective spinal surgeries, including minimally invasive techniques.
-
Robotics and Navigation: The company has made significant investments in robotics and navigation technologies to enhance surgical precision and outcomes. Their robotic systems aid in spinal fusion surgeries and aim to improve efficiency and accuracy during procedures.
-
Biologics: This segment addresses the need for biological materials that promote healing in spinal surgeries. Globus Medical offers a range of biologic products, including bone grafts, which can be used in conjunction with their spinal implants.
-
Innovative Technologies: Globus Medical continuously develops new technologies to improve the functionality and outcomes of spinal surgeries. This includes partnerships, acquisitions, and investments in cutting-edge spinal surgery technologies.
-
Global Expansion: Though not a product segment per se, Globus Medical has been expanding its geographical reach to increase its market presence internationally. This includes entering emerging markets and establishing a foothold in various countries.
Overall, Globus Medical focuses on innovation, quality, and comprehensive solutions for spinal surgery, aiming to improve patient outcomes and provide value to healthcare providers.
Globus Medical Inc. possesses several unique competitive advantages that differentiate it from its rivals in the medical device industry, particularly in the spinal and orthopedic sectors. Here are some key advantages:
-
Innovative Product Portfolio: Globus Medical focuses heavily on research and development, leading to the creation of advanced surgical technologies and products. Their commitment to innovation enables them to introduce state-of-the-art solutions that can outperform competitors' offerings.
-
Strong Intellectual Property: The company has built a robust patent portfolio, protecting its proprietary technologies and products. This legal safeguard provides a competitive edge by limiting the ability of rivals to replicate their innovations.
-
Focused Market Strategy: Globus Medical strategically concentrates on the spinal implant and surgical device markets. This focus allows the company to develop specialized products that better meet the specific needs of surgeons and patients compared to more diversified competitors.
-
Direct Sales Force: Globus employs a highly skilled direct sales team that fosters strong relationships with healthcare professionals. This direct approach allows for tailored customer service and immediate feedback, facilitating improved product development and customer satisfaction.
-
Rapid Product Development Cycle: The company has streamlined its product development processes, allowing for quicker response times to market needs and faster rollout of new products. This agility is advantageous in a rapidly changing healthcare environment.
-
Educational Support and Training Programs: Globus Medical invests in comprehensive training and educational programs for surgeons and medical staff. By enhancing the skill set and knowledge of users, the company not only supports better patient outcomes but also builds loyalty among clinicians.
-
Focus on Value-Based Care: The shift in healthcare towards value-based care aligns well with Globus’s focus on developing products that improve patient outcomes and reduce costs. Their emphasis on efficacy and efficiency can give them an edge over competitors who may still prioritize volume over value.
-
Strong Financial Position: Globus Medical has demonstrated solid financial growth, giving it the ability to invest in new technologies, marketing, and expansion efforts. A strong balance sheet can provide a competitive advantage in terms of funding research, acquisitions, or navigating market downturns.
-
Global Expansion Strategy: The company is strategically expanding its presence in international markets, potentially accessing new customer bases and diversifying revenue streams. This global approach can enhance resilience against domestic market fluctuations.
In summary, through its innovative approach, strong focus on specific markets, robust relationships with healthcare professionals, and commitment to value-based outcomes, Globus Medical Inc. has established a competitive edge in the medical device industry. These advantages position the company favorably to compete effectively against its rivals.
Globus Medical Inc., a company focused on musculoskeletal solutions, faces several risks and challenges in the near future. Here are some key factors to consider:
-
Regulatory Challenges: The medical device industry is heavily regulated. Changes in regulations or delays in obtaining necessary approvals for new products can impact the company’s ability to bring innovations to market.
-
Market Competition: The musculoskeletal device market is competitive, with several established players and new entrants. Increased competition could impact pricing, market share, and profit margins.
-
Product Development Risks: The company relies on its pipeline of new products. Challenges in development, such as technical difficulties or negative clinical trial results, could hinder growth prospects.
-
Reimbursement Environment: Changes in reimbursement policies from insurers and government programs can affect sales. If new products are not covered or are only partially reimbursed, it could limit adoption.
-
Economic Conditions: Economic downturns can lead to reduced healthcare spending, impacting surgery rates and demand for medical devices. Hospitals and clinics may delay purchasing decisions due to budget constraints.
-
Supply Chain Disruptions: Global supply chain issues, including shortages of materials or transportation delays, can impact production and delivery timelines.
-
Cybersecurity Risks: As a medical technology company, Globus Medical may be vulnerable to cyberattacks, which could jeopardize sensitive patient data and company operations.
-
Litigation Risks: The medical device industry is prone to lawsuits, which could lead to financial liabilities and damage the company’s reputation.
-
International Market Risks: Expansion into international markets carries risks related to differing regulations, cultural differences, and economic instability.
-
Dependency on Key Personnel: The loss of key management or technical personnel could hinder operations and innovation, impacting long-term strategy.
Addressing these challenges requires proactive management strategies, continuous innovation, and a strong compliance framework to navigate the evolving landscape of the medical device industry.
Revenue & Expenses Breakdown
Globus Medical Inc
Balance Sheet Decomposition
Globus Medical Inc
Current Assets | 2.1B |
Cash & Short-Term Investments | 694.7m |
Receivables | 593.2m |
Other Current Assets | 768.6m |
Non-Current Assets | 3B |
Long-Term Investments | 12.3m |
PP&E | 622.3m |
Intangibles | 2.3B |
Other Non-Current Assets | 120.4m |
Current Liabilities | 818.1m |
Accounts Payable | 57.5m |
Accrued Liabilities | 265.3m |
Other Current Liabilities | 495.3m |
Non-Current Liabilities | 198.6m |
Long-Term Debt | 709k |
Other Non-Current Liabilities | 197.9m |
Earnings Waterfall
Globus Medical Inc
Revenue
|
2.5B
USD
|
Cost of Revenue
|
-1B
USD
|
Gross Profit
|
1.4B
USD
|
Operating Expenses
|
-1.3B
USD
|
Operating Income
|
168.6m
USD
|
Other Expenses
|
-77.1m
USD
|
Net Income
|
91.5m
USD
|
Free Cash Flow Analysis
Globus Medical Inc
USD | |
Free Cash Flow | USD |
In Q3 2024, Globus Medical saw revenues reach $625.7 million, a 63.1% increase fueled by the NuVasive merger. Non-GAAP EPS grew 45% to $0.83 with record free cash flow of $161.7 million. The U.S. Spine segment grew 55%, showcasing strong product demand and increased sales efficiency. Globus anticipates full-year sales between $2.49 billion and $2.5 billion, representing a 3.9% to 4.3% rise over the previous year. They expect gross profit margins to improve to mid-70s in the near future as integration synergies materialize. Excitingly, 2025 is forecasted as a pivotal growth year as they enhance product portfolios and expand market reach.
What is Earnings Call?
GMED Profitability Score
Profitability Due Diligence
Globus Medical Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Globus Medical Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
GMED Solvency Score
Solvency Due Diligence
Globus Medical Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Score
Globus Medical Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GMED Price Targets Summary
Globus Medical Inc
According to Wall Street analysts, the average 1-year price target for GMED is 92.35 USD with a low forecast of 80.8 USD and a high forecast of 105 USD.
Dividends
Current shareholder yield for GMED is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
GMED Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 2,400 full-time employees. The company went IPO on 2012-03-08. The company is focused on implants that promote healing in patients with musculoskeletal disorders, including the use of a robotic guidance and navigation system and products to treat orthopedic traumas. The company groups its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities as well as the hip. Its Enabling Technologies are comprised of imaging, navigation, and robotics (INR) solutions for assisted surgery. The company offers solutions that facilitate both open and minimally invasive surgery (MIS) techniques. The company includes traditional fusion implants, such as pedicle screw and rod systems.
Contact
IPO
Employees
Officers
The intrinsic value of one GMED stock under the Base Case scenario is 85.38 USD.
Compared to the current market price of 84.72 USD, Globus Medical Inc is Undervalued by 1%.